Basic Information
ORBIO Corporation Develops and Deploys Unprecedented Cancer Diagnosis and Treatment Methods Using L-Glucose as a Lead Molecule, Integrating Knowledge from Medicine, Biology, Chemistry, and Physics. Collaborating with Scientists Utilizing New Knowledge Related to L-Glucose, ORBIO Corporation Will Provide a New Approach to Controlling Cancer.
ORBIO Corporation
Kyoto,Kyoto,Japan
less than 15 people
April 01, 2018
--

